Key facts, as of
As of November 9, 2026, Align Technology (ALGN) trades at $174.26, up 29.2% over the past year. Its 52-week range runs from $130.23 to $200.44; the price is 13.1% below that high. It is 76.4% below its all-time high of $737.45, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +74.5%, against +316.3% for the S&P 500 (SPY). It sits 3.4% above its 200-day average of $168.59. Its 30-day volatility is 44.1% annualized, which we rate high risk. It has a trailing P/E of 25.4.
Cite: Portfolio Terminal, "Align Technology (ALGN) stock analysis", 2026-11-09. https://portfolio-terminal.com/analyse/algn
Where it trades today
trading 63% of the way up its 52-week range
How the price has moved
How far it is from its record
Align Technology (ALGN) is 76.4% below its all-time high of $737.45, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +74.5%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- ALGN closes above its 50-day average ($150.71) while the 50-day is still under the 200-day ($168.59): a rebound inside a longer decline, not yet an uptrend.
- At $174.26, ALGN is 13.1% below its 1-year high of $200.44, set on April 21, 2026, and 33.8% above its 1-year low of $130.23 (November 18, 2025).
- Over the past month ALGN rose 22.1%, from $142.71 to $174.26.
- ALGN trades at 25.4x its last twelve months of earnings and 14.2x the next twelve months' estimate, so analysts expect earnings 79.3% higher.
- Its P/E is 26.8% below the 34.7x median of the 3 other medical devices companies we track (ABT, SYK, BSX).
- ALGN's 30-day volatility, 44.1% a year, works out to a typical daily move of about 2.8%.
- Yahoo Finance puts its beta at 1.74: over five years of monthly returns, ALGN moved about 1.74% for each 1% move of the S&P 500.
- The last session traded 2.3x ALGN's average daily volume of the 30 sessions before it.
What would change the read
- The rebound holds while it closes above the 50-day average, $150.71 (−13.5%); it becomes an uptrend when the 50-day climbs 11.9% to cross the 200-day at $168.59.
- A close above $200.44 (+15.0%) would be a new 1-year high; below $130.23 (−25.3%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for ALGN, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under medical devices among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for ALGN by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for ALGN. Last refresh: Nov 9, 2026, 9:37 PM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Medical Devices.
What Align Technology does
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus;…
Employees
20,180
Industry
Medical Instruments & Supplies
Headquarters
Tempe, United States
What analysts expect
ALGN carries a buy consensus from 14 analysts, with an average price target of $185.79 versus $174.26 today (+6.6%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
ALGN generated $4.16B in trailing revenue (1.9% year over year), with a 11.8% net margin, and $573.70M of free cash flow, supported by $998.47M of net cash.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $4.03B | $2.71B | $585.31M | $410.35M | $5.66 | $490.78M |
| 2024 | $4.00B | $2.80B | $671.76M | $421.36M | $5.63 | $622.65M |
| 2023 | $3.86B | $2.71B | $656.65M | $445.05M | $5.82 | $608.06M |
| 2022 | $3.73B | $2.63B | $654.05M | $361.57M | $4.62 | $276.83M |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
ALGN is in 11 of the 54 ETFs we track. It weighs most in RSP: 0.19% of the fund, holding #340 of 504.
How its figures compare with those peers
Companies in the same industry
ALGN beside the other companies Yahoo Finance files under medical devices among the assets we track (ABT, SYK, BSX, largest first).
What the chart is saying
Back above its 50-day average, still under the long-term trend.
recovering- Price is 15.6% above its 50-day average and 3.4% above its 200-day.
- The 50-day crossed below the 200-day on 2026-09-09 (a “death cross”).
- RSI at 70 is overbought: strong momentum, and stretched.
- The nearest ceiling is $175.89 (+0.9%), the nearest floor $164.77 (-5.4%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is ALGN valued right now?
Align Technology trades at 25.4 times its last twelve months of earnings and 14.2 times the next twelve months' estimate (Yahoo Finance, November 9, 2026). On the chart: back above its 50-day average, still under the long-term trend. Price is 15.6% above its 50-day average and 3.4% above its 200-day.
What is the risk level of ALGN?
Based on 30-day volatility of 44.1%, ALGN has HIGH risk. Its beta of 1.74 means it has swung more than the S&P 500 over the last five years.
Does ALGN pay dividends?
Yahoo Finance shows no dividend yield for Align Technology (November 9, 2026).
How far is ALGN from its all-time high?
Align Technology is 76.4% below its all-time high of $737.45, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +74.5%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold ALGN?
11 of the 54 popular ETFs we track hold Align Technology. The largest weights: RSP (0.19%), XLV (0.15%), VB (0.12%), CSPX (0.01%) and SPY (0.01%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is ALGN?
0.01%, as of September 30, 2026: ALGN is holding #482 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.15 in Align Technology.
What is the analyst price target for ALGN?
The average analyst price target for Align Technology (ALGN) is $185.79 based on 14 analyst estimates, about 6.6% above the current price of $174.26. The published range runs from $160.00 to $210.00.
How much revenue does ALGN generate?
Align Technology reported $4.16B in trailing twelve-month revenue. Revenue growth is running at 1.9% year over year. Net margin sits at 11.8%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare ALGN with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.